How To Navigate Drug Repurposing And Bridging Studies
Source: Life Science Leader
By Barbara Binzak Blumenfeld
Drug repurposing is not a new concept. However, the COVID-19 pandemic prompted many companies to consider whether a drug approved for one indication had a place in doctors’ and pharmacists’ armamentarium of treatment options for an emerging disease. The antiviral medication Remdesivir, originally developed to treat hepatitis C, was one of the most high-profile repurposed drugs to emerge during the pandemic, receiving both an emergency use authorization and an approval from the FDA for the treatment of COVID-19 patients.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more